tiprankstipranks
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market

Prelude Therapeutics (PRLD) Technical Analysis

99 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Prelude Therapeutics’s (PRLD) Moving Averages Convergence Divergence (MACD) indicator is 0.22, suggesting Prelude Therapeutics is a Buy.
Prelude Therapeutics’s (PRLD) 20-Day exponential moving average is 4.51, while Prelude Therapeutics’s (PRLD) share price is $4.74, making it a Buy.
Prelude Therapeutics’s (PRLD) 50-Day exponential moving average is 4.13, while Prelude Therapeutics’s (PRLD) share price is $4.74, making it a Buy.

Prelude Therapeutics (PRLD) Pivot Points

Apr 27, 2024, 07:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.22
4.39
4.58
4.75
4.94
5.11
5.30
Fibonacci
4.39
4.53
4.61
4.75
4.89
4.97
5.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prelude Therapeutics (PRLD) Moving Averages

Apr 27, 2024, 07:54 PM
Period
Simple
Exponential
MA5
4.69Buy
4.71Buy
MA10
4.73Buy
4.66Buy
MA20
4.53Buy
4.51Buy
MA50
3.91Buy
4.13Buy
MA100
3.73Buy
3.91Buy
MA200
3.65Buy
4.13Buy
Prelude Therapeutics’s (PRLD) 10-Day exponential moving average is 4.66, while Prelude Therapeutics’s (PRLD) share price is $4.74, making it a Buy.
Prelude Therapeutics’s (PRLD) 100-Day exponential moving average is 3.91, while Prelude Therapeutics’s (PRLD) share price is $4.74, making it a Buy.
Prelude Therapeutics’s (PRLD) stock price is $4.74 and Prelude Therapeutics’s (PRLD) 50-day simple moving average is 3.91, creating a Buy signal.
Prelude Therapeutics’s (PRLD) stock price is $4.74 and Prelude Therapeutics’s (PRLD) 100-day simple moving average is 3.73, creating a Buy signal.
Prelude Therapeutics’s (PRLD) stock price is $4.74 and Prelude Therapeutics’s (PRLD) 200-day simple moving average is 3.65, creating a Buy signal.

Prelude Therapeutics (PRLD) Technical Indicators

Apr 27, 2024, 07:54 PM
Name
Value
Implied Action
RSI (14)
59.30
Neutral
STOCH (9,6)
58.17
Neutral
STOCHRSI (14)
74.08
Neutral
MACD (12,26)
0.22
Buy
ADX (14)
30.61
Neutral
Williams %R
-23.72
Buy
CCI (14)
90.51
Neutral
ATR (14)
0.36
-
Ultimate Oscillator
40.24
Neutral
ROC
7.24
Buy
Prelude Therapeutics’s (PRLD) Relative Strength Index (RSI) is 59.30, creating a Neutral signal.
Prelude Therapeutics’s (PRLD) Trend Strength Indicator (ADX) is 30.61, creating a Neutral signal.
Prelude Therapeutics’s (PRLD) Commodity Channel Index (CCI) is 90.51, creating a Neutral signal.
Prelude Therapeutics’s (PRLD) Price Rate of Change (ROC) is 7.24, creating a Buy signal.

FAQ

Is PRLD a Buy, Hold, or Sell?
Based on PRLD’s technical indicators, PRLD is a Strong Buy.
    What is PRLD’s RSI (14)?
    PRLD’s RSI (14) is 59.30, which suggests PRLD is a Neutral.
      What is PRLD’s MACD?
      PRLD’s MACD is 0.22, which suggests PRLD is a Buy.
        What is PRLD’s 5-day moving average?
        PRLD’s 5-day moving average is 4.69, which suggests PRLD is a Buy.
          What is PRLD’s 20-day moving average?
          PRLD 20-day moving average is 4.53, which suggests PRLD is a Buy.
            What is PRLD’s 50-day moving average?
            PRLD’s 50-day moving average is 3.91, which suggests PRLD is a Buy.
              What is PRLD’s 200-day moving average?
              PRLD’s 200-day moving average is 3.65, which suggests PRLD is a Buy.
                What is PRLD’s Williams % R (14)?
                PRLD’s Williams % R (14) is -23.72, which suggests PRLD is a Buy.
                  What is PRLD’s CCI (14)?
                  PRLD’s CCI (14) is 90.51, which suggests PRLD is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis